Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015;7(6):975-84.
doi: 10.2217/epi.15.37. Epub 2015 May 1.

The role of piRNA and its potential clinical implications in cancer

Affiliations
Review

The role of piRNA and its potential clinical implications in cancer

Carolina Baraúna Assumpção et al. Epigenomics. 2015.

Abstract

Epigenetic mechanisms work in an orchestrated fashion to control gene expression in both homeostasis and diseases. Among small noncoding RNAs, piRNAs seem to meet the necessary requirements to be included in this epigenetic network due to their role in both transcriptional and post-transcriptional regulation. piRNAs and PIWI proteins might play important roles in cancer occurrence, prognosis and treatment as reported previously. Nevertheless, the potential clinical relevance of these molecules has yet been elucidated. A brief overview of piRNA biogenesis and their potential roles as part of an epigenetic network that is possibly involved in cancer is provided. Moreover, potential strategies based on the use of piRNAs and PIWI proteins as diagnostic and prognostic biomarkers as well as for cancer therapeutics are discussed.

Keywords: PIWI; cancer biomarker; cancer therapy; epigenetic network; piRNA.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Small noncoding RNAs involved in epigenetic regulation
Small noncoding RNAs seem to work in epigenetic control by regulating mRNAs in a post-transcriptional fashion. The profile of miRNAs and piRNAs depends on the specificity of transcripts in each cell. In cancer cells, the shift to global hypomethylation modifies the transcripts and as a consequence, the piRNAs and miRNAs profiles. This specificity allows miRNA and piRNA tissue signatures to be identified, both in homeostasis and in diseases.
Figure 2
Figure 2. Targeting piRNAs and PIWI proteins
Based on the roles of piRNAs and PIWI proteins, these molecules may be excellent targets for cancer therapy. Antibodies against PIWI proteins could be useful at the post-translational level, whereas synthetic piRNAs could be applied in transcriptional and posttranscriptional approaches. When targeting DNA, the ‘piRNAi’ should contain the specific sequence to allow them to associate with the PIWI proteins. Conversely, when targeting mRNA, the ‘piRNAi’ should contain the specific sequence to allow them to associate with proteins of the Argonaute family.

References

    1. Boumber Y, Issa JP. Epigenetics in cancer, what’s the future? Oncology (Williston Park) 2011;25(3):220–226. 228. - PubMed
    1. Tsai HC, Baylin SB. Cancer epigenetics, linking basic biology to clinical medicine. Cell Res. 2011;21(3):502–517. - PMC - PubMed
    1. You JS, Jones PA. Cancer genetics and epigenetics, two sides of the same coin? Cancer Cell. 2012;22(1):9–20. - PMC - PubMed
    1. Sharma A, Heuck CJ, Fazzari MJ, et al. DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer. Wiley Interdiscip Rev Syst Biol Med. 2010;2(6):654–669. - PubMed
    1. Jin B, Li Y, Robertson KD. DNA methylation, superior or subordinate in the epigenetic hierarchy? Genes Cancer. 2011;2(6):607–617. - PMC - PubMed